Clinical

Dataset Information

0

Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer

ABSTRACT: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of irinotecan in treating patients who have metastatic or recurrent colorectal cancer.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2002537 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Clinical Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
| 2006232 | ecrin-mdr-crc
Clinical Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer
| 2003275 | ecrin-mdr-crc
Clinical SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer
| 2006976 | ecrin-mdr-crc
Clinical Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer
| 2004952 | ecrin-mdr-crc
Clinical Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer
| 2003409 | ecrin-mdr-crc
Clinical Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer
| 2006502 | ecrin-mdr-crc
Clinical BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer
| 2006586 | ecrin-mdr-crc
Clinical Olimersen and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
| 2004017 | ecrin-mdr-crc
Clinical NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer
| 2007222 | ecrin-mdr-crc
Clinical Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer
| 2006177 | ecrin-mdr-crc